Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Frenzel

Showing results (31-40 of 223) with videos related to

Pageof 23
Sort By:
Acta Radiologica (Stockholm, Sweden : 1987)|April 16, 2020
Impact of concentration and dilution of three macrocyclic gadolinium-based contrast agents on MRI signal intensity at 1.5T and 3T and different pulse sequences: results of a phantom study in human plasmaPavol Szomolanyi, Thomas Frenzel, Iris M Noebauer-Huhmann, et al.
Investigative Radiology|March 3, 2009
Impact of renal impairment on long-term retention of gadolinium in the rodent skin following the administration of gadolinium-based contrast agentsHubertus Pietsch, Philipp Lengsfeld, Thomas Steger-Hartmann, et al.
Academic Radiology|May 22, 2002
Comparative studies on the efficacy of MRI contrast agents in MRAHanns-Joachim Weinmann, Hans Bauer, Wolfgang Ebert, et al.
Investigative Radiology|May 13, 2025
In Vitro and In Vivo Stability Assessment of the Novel, Macrocyclic Gadolinium-Based Contrast Agent GadoquatraneStephan Gruendemann, Thomas Frenzel, Jessica Lohrke, et al.
European Journal of Radiology|December 17, 2009
Efficacy and safety of lanthanoids as X-ray contrast agentsHubertus Pietsch, Gregor Jost, Thomas Frenzel, et al.
Plos One|April 24, 2020
Investigation of potential adverse central nervous system effects after long term oral administration of gadolinium in miceDominik Nörenberg, Felix Schmidt, Karin Schinke, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 22, 2008
Gadolinium-based contrast agents and their potential role in the pathogenesis of nephrogenic systemic fibrosis: the role of excess ligandMartin A Sieber, Philipp Lengsfeld, Jakob Walter, et al.
Investigative Radiology|May 25, 2019
Comparison of the Relaxivities of Macrocyclic Gadolinium-Based Contrast Agents in Human Plasma at 1.5, 3, and 7 T, and Blood at 3 TPavol Szomolanyi, Martin Rohrer, Thomas Frenzel, et al.
Investigative Radiology|June 15, 2022
Preclinical Profile of Gadoquatrane: A Novel Tetrameric, Macrocyclic High Relaxivity Gadolinium-Based Contrast AgentJessica Lohrke, Markus Berger, Thomas Frenzel, et al.
EFSA Journal. European Food Safety Authority|July 11, 2025
Assessment of the 2024 post-market monitoring report of genetically modified oilseed rape 73496, Michele Ardizzone, Thomas Frenzel, et al.
Pageof 23

Showing results (31-40 of 223) with videos related to

Sort By:
Pageof 23
Acta Radiologica (Stockholm, Sweden : 1987)|April 16, 2020
Impact of concentration and dilution of three macrocyclic gadolinium-based contrast agents on MRI signal intensity at 1.5T and 3T and different pulse sequences: results of a phantom study in human plasmaPavol Szomolanyi, Thomas Frenzel, Iris M Noebauer-Huhmann, et al.
Investigative Radiology|March 3, 2009
Impact of renal impairment on long-term retention of gadolinium in the rodent skin following the administration of gadolinium-based contrast agentsHubertus Pietsch, Philipp Lengsfeld, Thomas Steger-Hartmann, et al.
Academic Radiology|May 22, 2002
Comparative studies on the efficacy of MRI contrast agents in MRAHanns-Joachim Weinmann, Hans Bauer, Wolfgang Ebert, et al.
Investigative Radiology|May 13, 2025
In Vitro and In Vivo Stability Assessment of the Novel, Macrocyclic Gadolinium-Based Contrast Agent GadoquatraneStephan Gruendemann, Thomas Frenzel, Jessica Lohrke, et al.
European Journal of Radiology|December 17, 2009
Efficacy and safety of lanthanoids as X-ray contrast agentsHubertus Pietsch, Gregor Jost, Thomas Frenzel, et al.
Plos One|April 24, 2020
Investigation of potential adverse central nervous system effects after long term oral administration of gadolinium in miceDominik Nörenberg, Felix Schmidt, Karin Schinke, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 22, 2008
Gadolinium-based contrast agents and their potential role in the pathogenesis of nephrogenic systemic fibrosis: the role of excess ligandMartin A Sieber, Philipp Lengsfeld, Jakob Walter, et al.
Investigative Radiology|May 25, 2019
Comparison of the Relaxivities of Macrocyclic Gadolinium-Based Contrast Agents in Human Plasma at 1.5, 3, and 7 T, and Blood at 3 TPavol Szomolanyi, Martin Rohrer, Thomas Frenzel, et al.
Investigative Radiology|June 15, 2022
Preclinical Profile of Gadoquatrane: A Novel Tetrameric, Macrocyclic High Relaxivity Gadolinium-Based Contrast AgentJessica Lohrke, Markus Berger, Thomas Frenzel, et al.
EFSA Journal. European Food Safety Authority|July 11, 2025
Assessment of the 2024 post-market monitoring report of genetically modified oilseed rape 73496, Michele Ardizzone, Thomas Frenzel, et al.
Pageof 23